Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Heart Failure in elderly Farveh Vakilian.M.D.Cardiologist Fellowship in HF Mashhad University of Medical Sciences Case 1 • An 80-year-old man with prior history of hypertension and myocardial infarction presented with progressive dyspnea on exertion and leg swelling for the past 6 months. • He denied dyspnea at rest, orthopnea, PND, cough, wheezing, or chest pain. • A physical examination revealed only mild pitting lower extremity edema. • He had neither jugular venous pressure elevation nor hepatojugular reflux. • On cardiac auscultation, his first and second heart sounds were regular; a third or fourth heart sound could not be appreciated. • On pulmonary examination, there were no râles or wheezing. • He had normal sinus rhythm on his electrocardiogram. • A chest x-ray revealed no cardiomegaly or pulmonary venous congestion. • He had a left ventricular ejection fraction of 35% by an echocardiogram done a week later. Case 2 • An 84-year-old woman with known heart failure presented with dyspnea for 4 weeks during which time she developed dyspnea and fatigue on minimal exertion and even at rest. • She also complained of orthopnea and reported that most of the past week she slept sitting • Her past medical history was remarkable for hypertension. • She also reported right upper quadrant pain associated with nausea and loss of appetite but no vomiting. • She had chronic leg swelling which has gotten so severe over the past several weeks that she could not wear her shoes. • She responded to her worsening symptoms by restricting her activities and did not see her physician. • her jugular venous pressure was elevated at 15 cm of water. • She had no pulmonary râles or wheezing. • She had severe bilateral pitting edema in both of her legs up to mid-thigh areas with multiple blisters over lower legs. • She also had evidence of venous insufficiency with brown pigmentation and induration of skin. • She had normal sinus rhythm by an electrocardiogram. • Her chest radiograph was remarkable for marked cardiomegaly and pulmonary venous congestion. • a subsequent echocardiogram revealed a left ventricular ejection fraction of >55%. DEFINITION Heart failure is a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or ejec blood. Dyspnea and fatigue, with or without some degree of leg swelling, are the cardinal symptoms of heart failure Hypertension and coronary artery disease are the two most common causes of heart failure in all ages, including older adults. DIAGNOSIS • Systolic and Diastolic heart failure • is based on left ventricular ejection fraction. An echocardiogram is the most commonly used test to determine left ventricular ejection fraction. With age, there is a decrease both in number and in function of myocytes, even without cardiovascular disease ENHANCED NECROSIS AND APOPTOSIS Impaired calcium metabolism and regulation, reflects an alteration of processes of contraction and relaxation Other changes,,, contractile proteins change with age ATP utilization detrimental increase in myocardial collagen content and development of fibrosis arterial vascular wall fibrosis, thickening, and stiffening Pulse pressure is an easily hemodynamic dependent marker can be a predictor of CHF in 4 years follow up in eldery • These mechanisms may cause HFpEF. Exercise capacity is primarily affected due to the lower heart rate increase during exercise and higher end-diastolic pressure stroke volume that is more preload dependent due to impaired relaxation • Elderly patients hospitalized for acute HF ar more likely to be female • have higher EF and a higher prevalence o HFpEF • CAD and diabetes are less common in the very elderly • They have an increased prevalence of comorbidities, including: AF, hypertension, cerebrovascular disease, anaemia, malignancy, and chronic kidney disease ,osteoarthritis, and depression, and polypharmacy Elevated IL-6, was associated with increased risk of CHF in people without prior myocardial infarction. Symptoms and signs • Less than 50% of systolic dysfunction patients recognizaed in clinic • Reliance cannot be placed on classic symptoms of heart failure, and weight should be measured daily • Shortness of breath, orthopnea or nocturnal cough and paroxysmal nocturnal dyspnea • nonspecificity of complaints of fatigue, ascribing of symptoms to aging or comorbid conditions, • reduction in activities to avoid symptoms • memory impairment leading to poor historical information. • Physical examination may not be as definitive as in younger individuals. • Rales and third sounds are usualy heard in decompensations • jugular venous pressure and is likely to underestimate jugular venous pressure. In one study • only 14% had elevated jugular venous pressure. • NT-proBNP can help in diagnosis but • cutoffs for heart failure diagnosis are age specific, • almost fourfold higher cutoff value for patients older than 75 years Management o Elderly patients with heart failure have the highest rehospitalization rate of all adult patient groups. o Education and involvement of the patient, family members, and caregivers are key to the management of older patients o understanding of medication regimens, diet adjustments, and regular moderate physical activity should be emphasized. A change in mental status is common in elderly people with heart failure, especially those with vascular dementia with extensive cerebrovascular atherosclerosis or those who have latent Alzheimer disease. Multidisciplinary team,nurse directed approaches with patient contacts between office visits and more frequent contact during the transitional period after hospital discharge can be highly beneficial and reduce rehospitalization rates it is critical for clinicians to discuss end-of-life issues with patients and their families as soon as possible. Age-associated changes in pharmacokinetics must be taken into account when prescribing drugs for heart failure. NSAID related CHF risk is more than GI track damage so NSAID should be given with caution in eldery • Dietary sodium restriction(less than 3g/day) and moderate physical activity should be encouraged • Supervised exercise training programs based on cardiac rehabilitation algorithms have shown modest benefit • Fluid restriction depends on the patient’s clinical status • While it is not necessary to limit fluid intake in the absence of retention, a limit of 2 L/day is recommended if edema is detected. • If volume overload is severe, the limit should be 1 L/day. • Calories and fat intake are both important to watch, • particularly in patients with obesity, hyperlipidemia, hypertension, or coronary artery disease. Treatment • more recent usual therapy is an ACEinhibitor or ARB • beta blocker plus a diuretic, with lower rates of digoxin use • DIG trial analyses suggest that a morbidity and hospitalization benefit can accompany digoxin concentrations between 0.5 and 0.9 ng/ml • spironolactone has been accompanied by increased incidence of hyperkalemia in older patients with heart failure, and close monitoring is necessary. • carefully controlled and monitored setting, dose titration resulted in lower daily doses in older patients, especially those older than 80 years. • Vasodilating beta blockers are usually considered and should be instituted at low doses during periods of clinical stability. • Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly. Direct vasodilators such as hydralazine and nitrates have a limited role in older patients because of the increased likelihood of orthostatic hypotension As the plasma albumin level diminishes with age, the free-drug concentration of salicylates and warfarin,which are extensively albuminbound, may increase. Revascularization therapies are considered in the setting of ischemia Cardiac resynchronization therapy can decrease hospitalizations and reduce mortality in selected patients with symptomatic systolic heart failure despite optimal medical therapy. The few highly selected patients older than 65 years who have received cardiac transplantation appear to have survival times similar to those of younger patients, • with slightly more morbidity and mortality due to the surgical procedure but lower rates of rejection compared with younger patients Approach to the ELDERY patients with HF • Symptoms may be nonspecific in the older patientsuspect heart failure. • Consider heart failure diagnosis in patients with fatigue, dyspnea, exercise intolerance, or low activity. • Diagnosis may be facilitated by use of echocardiography or serum markers of heart failure. • Heart failure may be present in the older patient with preserved systolic function especially in older women. • Aggressive treatment of hypertension or diabetes, when present, may improve heart failure outcomes. • Treat symptoms with a goal of improving quality of life and morbidity. • Control blood pressure-systolic and diastolic. • Treat ischemia. • Control atrial fibrillation rate. • Promote physical activity. • Adjust medications for age- and disease-related changes in kinetics and dynamics. • Educate and involve patients, family members, or caregivers in management of heart failure. • Monitor weight. • Consider use of multidisiplinary team approaches